Skip to main content
Equibles

UBS Group AG

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8
Back to INO Full portfolio

Position in INO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$288,550
-$145,839 QoQ
Shares Held
262,320
+5.1% QoQ
Ownership
0.254%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 101 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. INO ranks #322 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in INO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $288,550 262,320
2026-03-31 $434,389 249,650
2025-12-31 $296,805 170,579
2025-09-30 $685,763 293,062
2025-06-30 $407,344 199,679
2025-03-31 $338,822 207,867
2024-12-31 $323,861 176,974
2024-09-30 $79,272 13,715
2024-06-30 $221,318 27,391
2024-03-31 $26,593 1,916
2023-12-31 $26,761 52,475
2023-09-30 $21,492 55,110
2023-06-30 $3,202 7,118
2023-03-31 $655,270 799,112
2022-12-31 $1,429,956 916,640
2022-09-30 $523,544 302,627
2022-06-30 $1,045,343 604,245
2022-03-31 $5,887,642 1,640,012
2021-12-31 $4,105,347 822,715
2021-09-30 $3,273,107 457,138
2021-06-30 $892,644 96,294
2021-03-31 $1,002,620 108,041
2020-12-31 $507,237 57,315
2020-09-30 $628,047 54,142
2020-06-30 $1,369,679 50,823
2020-03-31 $246,635 33,150